Use of Video Consultation in Follow-up Care for Patients With a Neuroendocrine Tumor: a Feasibility Study

Neuroendocrine Tumor Clinical Trial

— VIDEO-NET  

Official title:

Use of Video Consultation in Follow-up Care for Patients With a NeuroEndocrine Tumor: a Feasibility Study (VIDEO-NET Study)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02147106
• Other study ID #: VIDEO-NET-2014
• Status: Completed
• Start date: May 2014
• Est. completion date: March 2017

Study information

• Verified date: May 2024
• Source: University Medical Center Groningen
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Rationale: Patients with neuroendocrine tumors (NET) have a rare disease. Due to treating patients with a neuroendocrine tumor in 'NET knowledge centers' patients often have to travel long distances for follow-up visits at the outpatient clinic. Patients whose medical condition allows videoconsultation could save time by replacing outpatient clinic visits through videoconsultation for receiving follow-up care. Therefore, in this study we aim to introduce videoconsultation as a alternative for follow-up outpatient clinic visits in NET patients.

Objective: The primary objective is to assess if use of videoconsultation in follow-up care for NET patients is feasible. We hypothesize that videoconsultation is a suitable medium for providing follow-up care in NET patients. Secondary objectives are to explore the amount of time videoconsultation takes in comparison with outpatient clinic visits and the acceptability and satisfaction of physicians and patients with using videoconsultation in follow-up care.

Study design: The present study is a single-centre prospective feasibility study.

Study population: Adult NET patients under surveillance or treatment of the department Medical Oncology at the University Medical Centre Groningen (UMCG) whose medical condition allows videoconsultation will be invited to participate.

Intervention: Patient who give informed consent will participate in the study. Participants will receive follow-up care through videoconsultation instead of conventional visits at the outpatient clinic.

Main study parameters/endpoints: The main endpoint is the feasibility of videoconsultation for follow-up care in NET patients. We hypothesize that videoconsultation is a suitable medium for providing follow-up care.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 26
• Est. completion date: March 2017
• Est. primary completion date: March 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Signed informed consent

• Age = 18 yrs

• Grade I or II (low and intermediate grade) NET with any primary tumor type or disease stage

• Have access to required equipment/technology for performing videoconsultation

Exclusion Criteria:

• Newly referred NET patients, who are visiting the department of Medical Oncology at the UMCG for the first time

• Recently diagnosed NET patients, who are in the diagnostic phase of the disease

• NET patients who frequently require blood tests, consultation or physical examination

• A hearing or visual impairment, which would make videoconsultation difficult

Related Conditions & MeSH terms

• Neuroendocrine Tumor
• Neuroendocrine Tumors

Intervention

Other:
• Videoconsultation

Locations

Country	Name	City	State
Netherlands	University Medical Center Groningen	Groningen

Sponsors (1)

Lead Sponsor	Collaborator
University Medical Center Groningen

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Feasibility	Participation rates, reason for declining participation, number of completed videoconsultations, dropout rate and reason for dropout will be noted in study records to evaluate feasibility of videoconsultation	1 year
Secondary	Amount of time	The amount of time NET patients are spending with videoconsultation in comparison with conventional outpatient clinic visits.	1 year
Secondary	Acceptability and satisfaction of patients	The acceptability and satisfaction of patients with the use of videoconsultation will be assessed with a questionnaire and open-ended questions.	1 year
Secondary	Acceptability and satisfaction of physicians	The acceptability and satisfaction of physicians with the use of videoconsultation will be assessed with a questionnaire and open-ended questions.	1 year